ParaZero Integrates its Safety Technology into Draganfly’s Commander 3XL Drones for Home Hospital Delivery and Emergency Response
April 25, 2024 07:19 ET
|
ParaZero Technologies Ltd.
Tel Aviv, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "Company” or “ParaZero”), an aerospace company focused on drone safety systems for commercial...
Draganfly Integrates ParaZero Safety Technology into Commander 3XL Drones for Home Hospital Delivery and Emergency Response
April 25, 2024 07:15 ET
|
Draganfly Inc
San Diego, CA., April 25, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and...
Altisource Announces First Quarter 2024 Financial Results
April 25, 2024 07:06 ET
|
Altisource Portfolio Solutions S.A.
LUXEMBOURG, April 25, 2024 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage...
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
April 25, 2024 07:01 ET
|
HOOKIPA Pharma Inc.
Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback ...
Nasdaq Announces 9% Increase in Quarterly Dividend to $0.24 Per Share
April 25, 2024 07:01 ET
|
Nasdaq, Inc.
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.24 per share on the company's outstanding common...
Valley National Bancorp Announces First Quarter 2024 Results
April 25, 2024 07:00 ET
|
Valley National Bank
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today reported net income for the first quarter 2024 of $96.3...
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
April 25, 2024 07:00 ET
|
Morphic Therapeutic
MORF ends 1Q24 with $659 million, cash into 2H27; phase 2b study of MORF-057 in UC continues on target; anticipate GARNET phase 2 in Crohn's to begin 2Q
Ultralife Corporation Reports First Quarter Results
April 25, 2024 07:00 ET
|
Ultralife Corporation
NEWARK, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2024 with the following highlights: Sales of...
BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024
April 25, 2024 07:00 ET
|
BioXcel Therapeutics
NEW HAVEN, Conn., April 25, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in...
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
April 25, 2024 07:00 ET
|
Cibus US LLC
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or...